Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North AmericaGlobeNewsWire • 04/18/22
Ocugen stock drops after FDA places clinical hold on study of COVID-19 vaccine candidate CovaxinMarket Watch • 04/12/22
3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall StreetThe Motley Fool • 04/06/22
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal DegenerationGlobeNewsWire • 04/01/22
3 Growth Stocks With Monster Upside of Up to 331%, According to Wall StreetThe Motley Fool • 03/30/22
Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of DirectorsGlobeNewsWire • 03/23/22
Ocugen, Inc. Appoints Jessica Crespo, CPA, to Chief Accounting Officer and Senior Vice President, FinanceGlobeNewsWire • 03/21/22